Micron Biomedical
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
311 Ferst Dr NW Ste L1309, Atlanta, Geor...Website
www.micronbiomedical.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Micron Biomedical
Micron is an Atlanta based company whose microneedle technology was initially developed at Georgia Tech in the lab of Mark Prausnitz, PhD. Co-founded by Dr. Prausnitz, Dr. McAllister, and Sebastien Henry, MS, MBA, Micron has advanced the technology and emerged as a leader in dissolving microneedle-based vaccine and drug delivery technology. Micron's partners and funders include public and private vaccine and pharmaceutical companies, the Centers for Disease Control and Prevention (CDC), the Bill & Melinda Gates Foundation (funding Micron's MR vaccination activities), UNICEF, and the Georgia Research Alliance.Explore more
Micron Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Micron Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Micron Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Micron Biomedical recently announced quarterly report
Product Launch: Get notified when Micron Biomedical launches new products
Check if Micron Biomedical has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Micron Biomedical
Check out if Micron Biomedical is spiking on competitors!
Funding: Get notified immidiatlly once Micron Biomedical has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Micron Biomedical had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Micron Biomedical
Compare insights from companies similar to Micron Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Micron Biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Micron Biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Micron Biomedical.
Micron Biomedical financials insights
Gather financial insights about Micron Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$17M
Micron Biomedical Tech Stack
A closer look at the technologies used by Micron Biomedical
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Bioengineering, Medical Research, Manufacturing Operations
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Executive Move
Board of Directors
Funding
Micron Biomedical News & Media
Micron Biomedical Celebrates the Grand Opening of Its Commercial-Scale Manufacturing Site in Georgia
National and local leaders across government, investors, life science industry and academia acknowledge the impact of Micron’s dissolvable vaccines and therapies on human health and economic development National and local leaders across government, investors, life science industry and academia acknowledge the impact of Micron’s dissolvable vaccines and therapies on human health and economic developmentMicron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered
Micron Biomedical makes the Most Innovative Companies List in recognition of clinical, financial and other progress toward needle-free vaccines and drugs.Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology
Next-generation rotavirus vaccine delivered via dissolvable microarray technology addresses leading cause of diarrheal deaths in kids 5 years and youngerMicron Biomedical Names Health Education and Empowerment Advocate, Dr. Jayne Morgan, to Board of Advisors
Dr. Jayne Morgan joins Micron Biomedical's Board of Advisors to promote public education on vaccines and therapeutics delivered without needles.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Micron Biomedical
Sign Up For FreeTo access detailed company insights
Micron is an Atlanta based company whose microneedle technology was initially developed at Georgia Tech in the lab of Mark Prausnitz, PhD. Co-founded by Dr. Prausnitz, Dr. McAllister, and Sebastien Henry, MS, MBA, Micron has advanced the technology and emerged as a leader in dissolving microneedle-based vaccine and drug delivery technology. Micron'... Read More
